
CueZen
Precision digital therapy for chronic disease management with AI-driven personalized care programs.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 Valuation: €0.0 | round | |
* | $5.0m | Seed | |
Total Funding | 000k |
Related Content
CueZen specializes in precision digital therapy, leveraging AI to enhance chronic disease management for health systems and insurance companies. The company integrates AI capabilities into existing care programs, providing personalized behavioral cues to optimize patient outcomes. Trusted by health ministries, large payors, and integrated delivery networks (IDNs), CueZen's platform is designed to improve care program efficacy through real-time integration and device optimization. The business model focuses on embedding AI-driven content and program recommendations across various channels, utilizing predictive models and behavioral therapies to target conditions like osteoarthritis. CueZen's approach includes phenotyping to segment populations based on behavioral, medical, and social determinants of health data, enabling advanced AI-driven care pathway predictions. The company serves a diverse client base, including health systems and insurance providers, aiming to reduce post-surgical complications and disease progression through personalized nudges and telemetry tracking. Keywords: precision therapy, AI integration, chronic disease, personalized care, health systems, insurance, predictive models, phenotyping, care pathways, behavioral cues.